Report about VIVEbiotech in El Confidencial

On the occasion of being a finalist for the 2020 Pyme Award, Banco Santander has made known the great work we do at VIVEbiotech manufacturing lentiviral vectors for application in clinical trials in humans to try to contribute to the cure of diseases, “not only rare diseases, but also some cancers such as leukemias, lymphomas or myelomas, with recoveries in this case of up to 90% of patients”.

Thanks to Banco Santander for its support, for the 2020 Gipuzkoa SME Award, and for letting the Spaniards know who we are and what we do.

To read the infomercial, click here.